Octagon Capital Partners logo

Octagon Capital Partners

North America, Ontario, Canada, Toronto

Description

Independent Canadian investment dealer

Investor Profile

Octagon Capital Partners has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Canada, China, United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (80%)
  • Series Unknown (20%)

Country Focus

  • Canada (40%)
  • China (40%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Mental Health
  • Product Research
  • Electronics
  • Hardware
  • Management Information Systems
  • Manufacturing
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Octagon Capital Partners frequently co-invest with?

Altium Capital
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
8VC
North America, California, United States, San Francisco
Co-Investments: 1
Avidity Partners
North America, Texas, United States, Dallas
Co-Investments: 2
Sphera Global Healthcare Fund
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1
Acorn Bioventures
North America, New York, United States, New York
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Octagon Capital Partners?

Cybin

Toronto, Ontario, Canada

Cybin is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

BiotechnologyHealth CareMental HealthPharmaceutical
Post Ipo EquityMar 13, 2024
Amount Raised: $150,000,000
Sonoma Pharmaceuticals

Petaluma, California, United States

Sonoma Pharmaceuticals develops and markets a global array of treatments for dermatological conditions and advanced tissue care.

Health Care
Post Ipo EquitySep 30, 2020
Amount Raised: $70,000,000
I-Mab Biopharma

Shanghai, Shanghai, China

I-Mab is a dynamic and fast-growing global biotech company exclusively focused on developing innovative biologics.

BiotechnologyPharmaceuticalProduct Research
Post Ipo EquitySep 4, 2020
Amount Raised: $418,000,000
Labrador Iron Mines

Toronto, Ontario, Canada

Labrador Iron Mines is a resource extraction company.

HydroelectricMiningMining TechnologyService Industry
Post Ipo EquityFeb 29, 2012
Amount Raised: $72,452,260
SinoHub

Shenzhen, Guangdong, China

SinoHub was a one-stop-shop for all electronic component supply chain services.

ElectronicsHardwareManagement Information SystemsManufacturingSoftwareSupply Chain Management
Series UnknownFeb 24, 2010
Amount Raised: $4,610,000

Find More Investors Like Octagon Capital Partners

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Octagon Capital Partners | Pipeseed